CHM gets the anns, hardly any reaction. But ALA runs again. Hi Merchant Fund, why not investing in CHM as well?
GLTA
Ann: Phase 1B brain cancer clinical trial approved for initiation, page-7
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CHM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.40M | |||
| Open | High | Low | Value | Volume |
| 1.5¢ | 1.5¢ | 1.5¢ | $7.588K | 505.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 21 | 1919600 | 1.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.6¢ | 28828 | 1 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| CHM (ASX) Chart |